Here's the live share price of Aarti Pharmalabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Aarti Pharmalabs has gained 14.25% CAGR. Over the past year, the corresponding return has been 29.94%.
Aarti Pharmalabs’s current P/E of 27.53x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aarti Pharmalabs | -1.93 | 2.87 | -18.55 | -16.60 | 29.83 | 24.86 | 14.25 |
| Sun Pharmaceutical Industries | -2.79 | -0.19 | 6.52 | 6.60 | -2.44 | 21.11 | 24.99 |
| Divi's Laboratories | -1.49 | -2.15 | 3.83 | -3.09 | 8.34 | 23.73 | 10.60 |
| Torrent Pharmaceuticals | -1.92 | -1.71 | 4.52 | 15.54 | 10.29 | 32.82 | 21.96 |
| Cipla | -0.91 | -1.07 | -5.07 | 0 | 1.79 | 10.95 | 13.53 |
| Dr. Reddy's Laboratories | -0.56 | 1.79 | -4.28 | -3.57 | -0.72 | 12.86 | 3.87 |
| Lupin | 0.94 | 2.58 | 2.64 | 7.49 | 0.06 | 42.33 | 16.66 |
| Zydus Lifesciences | -0.99 | -1.61 | -12.84 | -4.65 | -6.72 | 30.67 | 13.90 |
| Mankind Pharma | -3.06 | -5.56 | -20.38 | -10.78 | -25.13 | 13.87 | 8.11 |
| Aurobindo Pharma | 0.81 | -4.64 | 4.74 | 6.77 | -5.28 | 39.30 | 5.96 |
| Alkem Laboratories | -0.97 | -2.47 | 1.67 | 15.94 | 1.55 | 22.90 | 13.50 |
| Abbott India | -2.58 | -7.38 | -11.07 | -12.72 | -2.25 | 9.62 | 11.22 |
| Glenmark Pharmaceuticals | -1.44 | 4.70 | -8.61 | 16.15 | 26.51 | 66.52 | 30.09 |
| Laurus Labs | -1.66 | -0.48 | 8.47 | 50.91 | 76.48 | 37.27 | 23.15 |
| Biocon | 1.59 | -8.06 | 5.23 | 13.28 | 11.40 | 13.86 | -3.81 |
| GlaxoSmithKline Pharmaceuticals | -3.99 | 1.27 | -8.37 | -23.30 | 7.90 | 23.69 | 9.35 |
| Anthem Biosciences | -3.83 | -0.05 | -22.94 | -9.80 | -9.80 | -3.32 | -2.00 |
| Ipca Laboratories | -5.51 | -2.40 | 3.82 | 1.96 | -8.37 | 17.61 | 4.49 |
| Ajanta Pharma | -3.02 | 4.48 | 0.92 | -0.38 | -11.12 | 29.73 | 18.52 |
| J B Chemicals & Pharmaceuticals | -1.76 | -0.93 | 5.40 | 3.66 | -3.98 | 20.06 | 27.34 |
Over the last one year, Aarti Pharmalabs has gained 29.83% compared to peers like Sun Pharmaceutical Industries (-2.44%), Divi's Laboratories (8.34%), Torrent Pharmaceuticals (10.29%). From a 5 year perspective, Aarti Pharmalabs has outperformed peers relative to Sun Pharmaceutical Industries (24.99%) and Divi's Laboratories (10.60%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 735.14 | 743.73 |
| 10 | 722.49 | 733.19 |
| 20 | 711.64 | 732.8 |
| 50 | 776.93 | 765.83 |
| 100 | 825.06 | 795.44 |
| 200 | 818.29 | 787.7 |
In the latest quarter, Aarti Pharmalabs saw a drop in promoter holding to 42.90%, while DII stake decreased to 6.95%, FII holding rose to 8.02%, and public shareholding moved up to 42.12% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 4,28,834 | 0.15 | 30.05 | |
| 1,00,000 | 0.49 | 7.01 | |
| 1,00,000 | 0.49 | 7.01 | |
| 72,058 | 1.38 | 5.05 | |
| 67,500 | 0.02 | 4.73 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Nov 17, 2025, 10:59 PM IST | Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Nov 12, 2025, 12:13 AM IST | Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Nov 11, 2025, 1:48 PM IST | Aarti Pharmalabs - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Nov 09, 2025, 9:57 PM IST | Aarti Pharmalabs - Financial Results For Quarter And Half Year Ended September 30, 2025 |
| Nov 09, 2025, 8:56 PM IST | Aarti Pharmalabs - Board Meeting Outcome for Board Meeting Outcome For Financial Results For The Quarter And Half Year Ended |
Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1771.35 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aarti Pharmalabs is ₹732.70 as on Dec 18, 2025.
The Aarti Pharmalabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Aarti Pharmalabs is ₹6,599.12 Cr as on Dec 18, 2025.
Today’s highest and lowest price of Aarti Pharmalabs are ₹739.95 and ₹726.05.
The 52-week high/low is the highest and lowest price at which Aarti Pharmalabs stock has traded in the past 52-week or nearly a year. The 52-week high of Aarti Pharmalabs is ₹971.50 and 52-week low of Aarti Pharmalabs is ₹550.25 as on Dec 18, 2025.
The Aarti Pharmalabs has shown returns of 0.41% over the past day, 2.97% for the past month, -18.48% over 3 months, 29.94% over 1 year, 24.87% across 3 years, and 14.25% over 5 years.
P/E ratio of and PB ratio of Aarti Pharmalabs are 27.53 and 3.55 on Dec 18, 2025. While the company gives a dividend yield of 0.00 per annum.